1 Boston Scientific Corporation Exhibit 11 COMPUTATION OF PER SHARE EARNINGS Year Ended December 31, ------------------------------ 1996 1995 1994 ---- ---- ---- (in thousands, except per share information) Primary Average shares outstanding ................... 177,696 175,485 172,107 Net effect of dilutive stock options and warrants-based on the treasury stock method using average market price .................................. 3,597 2,049 2,090 -------- -------- -------- Total ........................................ 181,293 177,534 174,197 ======== ======== ======== Net income ................................... $167,106 $ 6,440 $135,307 ======== ======== ======== Per share amount ............................. $ 0.92 $ 0.04 $ 0.78 ======== ======== ======== Fully Diluted Average shares outstanding ................... 177,696 175,485 172,107 Net effect of dilutive stock options and warrants--based on the treasury stock method using year-end market price, if higher than average market price .................................. 5,031 2,272 2,594 -------- -------- -------- Total ........................................ 182,727 177,757 174,701 ======== ======== ======== Net income ................................... $167,106 $ 6,440 $135,307 ======== ======== ======== Per share amount ............................. $ 0.91 $ 0.04 $ 0.77 ======== ======== ========